Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs XWELL, Inc. (XWEL)

Advanced Biomed Inc. and XWELL, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. and XWELL, Inc. are of similar size ($8.1M and $7.5M). XWELL, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.8×. Advanced Biomed Inc. has the higher net margin (0.00% vs −117.8%) and the lower return on invested capital (−33.4% vs 0.00%). Across the 12 metrics below, Advanced Biomed Inc. leads on 10 and XWELL, Inc. on 2.

Valuation

Metric ADVB XWEL Diagnostics & Research median
P/E 0.77 n/m 35.56
P/S n/m 0.22 4.37
P/B 0.41 0.75 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 0.02 24.35
EV/Sales n/m (0.01) 5.51
Earnings yield 129.37% (728.77%) (1.89%)
Free cash flow yield (90.81%) (217.51%) (0.15%)

Profitability

Metric ADVB XWEL Diagnostics & Research median
Gross margin — 34.34% 50.89%
Operating margin 0.00% (61.31%) (8.57%)
Net margin 0.00% (117.83%) (6.37%)
Free cash flow margin 0.00% (47.65%) 0.00%
Return on equity 84.77% (557.21%) (2.92%)
Return on assets 36.47% (155.10%) (6.71%)
Return on invested capital (33.43%) 0.00% 0.00%

Growth

Metric ADVB XWEL Diagnostics & Research median
Revenue growth (TTM) — (7.58%) 7.69%
EPS growth (last fiscal year) 266.53% (38.80%) 25.92%
Revenue growth, 5-year CAGR — 28.35% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB XWEL Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 9.33 2.27 2.02
Net debt to EBITDA 0.06 (0.08) 0.70

Dividend

Metric ADVB XWEL Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ADVB XWEL Diagnostics & Research median
Market cap 8.06m 7.45m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack